Comparative effect of melatonin and vitamin e on phenylhydrazine-induced toxicity in the spleen of Funambulus pennanti

Environmental Toxicology

Volumn 24, Issue 1, 2009, Pages 1-9

  Sharma, Shweta ^a   Haldar, Chandana ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Melatonin; Oxidative stress; Phenylhydrazine; Seasonal breeder; Vitamin E

Indexed keywords

APOPTOSIS; BODY WEIGHTS; CARCINOGENIC PROPERTIES; CELL VIABILITIES; DOSE DEPENDENTS; FREE RADICAL GENERATIONS; HARMFUL EFFECTS; IRON RELEASE; LIPID PEROXIDATION; LYMPHOID TISSUES; MELATONIN; OXIDATIVE DAMAGES; PHENYLHYDRAZINE; RADICAL CATIONS; SCAVENGING ACTIVITIES; SEASONAL BREEDER; VITAMIN E;

CELL DEATH; OXIDATION; OXIDATIVE STRESS; SUPRAMOLECULAR CHEMISTRY; TOXICITY;

HORMONES;

ALPHA TOCOPHEROL; MELATONIN; PHENYLHYDRAZINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

APOPTOSIS; CANCER; COMPARATIVE STUDY; DAMAGE; DOSE-RESPONSE RELATIONSHIP; ECOTOXICOLOGY; FREE RADICAL; HORMONE; OXIDATION; POLLUTION EFFECT; RODENT; VIABILITY; VITAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BREED; CHEMICAL CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; FUNAMBULUS PENNANTI; HEMOLYSIS; INDIA; LEUKOCYTE COUNT; LIPID PEROXIDATION; LYMPHOID TISSUE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SEASONAL VARIATION; SPLEEN; SPLENOMEGALY; SQUIRREL; TROPICS;

ANIMALS; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPID PEROXIDATION; MALE; MELATONIN; OXIDATIVE STRESS; PHENYLHYDRAZINES; REPRODUCTION; SCIURIDAE; SPLEEN; SUPEROXIDE DISMUTASE; VITAMIN E;

FUNAMBULUS PENNANTI;

EID: 60349115535     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20383     Document Type: Article

References (52)

1. Antolin I, Rodriguez C, Sainz RM, Mayo JC, Uria H, Kotler ML, Rodriguez-Colunga MJ, Tolivia D, Menendez-Pelaez A. 1996. Neurohormone melatonin prevents cell damage: Effect on gene expression for antioxidant enzymes. FASEB J 10:882-890.
2. Bartosz G, Bartosz M. 1999. Antioxidant activity: What do we measure? Acta Biochim Pol 46:23-29.
3. Berger J. 2007. Phenylhydrazine heamatotoxicity. J Appl Biomed 5:125-130.
4. Biswas S, Bhattacharyya J, Dutta AG. 2005. Oxidant induced injury of erythrocyte-Role of green tea leaf and ascorbic acid. Mol Cell Biochem 276:205-210.
5. Blask DE, Wilson ST, Zalatan F. 1997. Physiological melatonin inhibition of human breast cancer cell growth in vitro: Evidence for a glutathione-mediated pathway. Cancer Res 57:1909-1914.
6. Bonkovsky HL. 1991. Iron and the liver. Am J Med Sci 301:32-43.
7. Das K, Samanta L, Chainy GBN. 2000. A modified spectrophoto-metric assay of superoxide dismutase using nitrite formation by superoxide radicals. Indian J Biochem Biophys 37:201-204.
8. Drazen DL, Bilu D, Bilbo SD, Nelson RJ. 2001. Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 280:R1476-R1482.
9. Ferrali M, Signorini C, Ciccoli L, Comporti M. 1992. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem J 285: 295-301.
10. Ferrali M, Signorini C, Sugherini L, Pompella A, Lodovici M, Caciotti B, Ciccoli L, Comporti M. 1997. Release of free, redox- active iron in the liver and DNA oxidative damage following phenylhydrazine intoxication. Biochem Pharmacol 53: 1743-1751.
11. Fraschini F, Demartini G, Esposti D, Scaglione F. 1998. Melatonin involvement in immunity and cancer. Biol Signals Recept 7:61-72.
12. Golab J, Olszewska D, Mroz P, Kozar K, Kaminski R, Jalili A, Jakobisiak M. 2002. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy- induced anemia. Clin Cancer Res. 8:1265-1270.
13. Gudima SO, Taylor JM. 2001. Search for antisense copies of beta- globin mRNA in anemic mouse spleen. BMC Biochem 2:3-7.
14. Haldar C, Singh R, Guchhait P. 2001. Relationship between the annual rhythms in melatonin and immune system status in the tropical palm squirrel, Funambulus pennanti. Chronobiol Int 18:61-69.
15. Haldar C, Rai S, Singh R. 2004. Melatonin blocks dexamethasone induced immunosuppression in a seasonally breeding rodent Indian palm squirrel, Funambulus pennanti. Steroids 69:367-377.
16. Herraiz T, Galisteo J. 2004. Endogenous and dietary indoles: A class of antioxidants and radical scavengers in the ABTS assay. Free Radic Res 38:323-331.
17. Imanishi H, Nakai T, Abe T, Takino T. 1985. Role of free radical scavengers on phenylhydrazine induced hemolysis in rat. Acta Vitaminol Enzymol 7:71-75.
18. Jung B, Ahmad N. 2006. Melatonin in cancer management: Progress and promise. Cancer Res 66:9789-9793.
19. Karbownik M, Reiter RJ, Garcia JJ, Tan D. 2000. Melatonin reduces phenylhydrazine induced oxidative damage to cellular membranes: Evidence for the involvement of iron. Int J Bio- chem Cell Biol 32:1045-1054.
20. Kean T, Miller JH, Skellern GG, Snodin D. 2006. Acceptance criteria for levels of hydrazine in substances for pharmaceutical use and analytical methods for its determination. Pharmeur Sci Notes 2006:23-33.
21. Liu F, Ng TB. 2000. Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues. Biochem Cell Biol 78:447-453.
22. Maestroni GJM, Conti A. 1989. Beta-endorphin and dinorphin mimic the circadian immunoenhancing and antistress effect of melatonin. Int Immunopharmacol 11:333-340.
23. Maestroni GJM, Conti A, Pierpaoli W. 1998. Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosup- pressive effect of acute stress via an opiatergic mechanism. Immunology 63:465-169.
24. Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Rodriguez C. 2002. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 59:1706-1713.
25. McMillan DC, Powell CL, Bowman ZS, Morrow JD, Jollow DJ. 2005. Lipids versus proteins as major targets of pro-oxidant, direct-acting hemolytic agents. Toxicol Sci 88:274-283.
26. Moloney SJ, Prough RA. 1983. Biochemical toxicology of hydra-zines. In: Hodgeson E, Bend JR, Philpot RM, editors. Reviews Biochemical Toxicology. New York: Elsevier. pp 313-346.
27. Nelson RJ, Drazen DL. 2000. Melatonin mediates seasonal changes in immune function. Ann NY Acad Sci 917:404-415.
28. Ohkawa H, Ohishi N, Yagi K. 1978. Reaction of linoleic acid hydro-peroxide with thiobarbituric acid. J Lipid Res 19:1053-1057.
29. Paiva LM, Pinto GF, Oestreicher EG. 1991. Inhibition of horse liver alcohol dehydrogenase and rabbit muscle lactate dehydro-genase by phenylhydrazine. Biomed Biochim Acta 50:25-9.
30. Parodi S, Flora SD, Cavanna M, Pino A, Robbiano L, Bennicelli C, Brambilla G. 1981. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. Cancer Res 41:1469-1482.
31. Petranka J, Baldwin W, Biermann J, Jayadev S, Barrett JC, Murphy E. 1999. The oncostatic action of melatonin in an ovarian carcinoma cell line. J Pineal Res 26:129-136.
32. Pieri C, Marra M, Moroni F, Decchioni R, Marcheselli F. 1994. Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci 55:271-276.
33. Rai S, Haldar C. 2003. Pineal control of immune status and hematological changes in blood and bone marrow of male squirrels (Funambulus pennanti) during their reproductively active phase. Comp Biochem Physiol C Toxicol Pharmacol 136:319-328.
34. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice- Evans C. 1999. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231-1237.
35. Reiter RJ. 1995. The role of the neurohormone melatonin as a buffer against macromolecular oxidative damage. Neurochem Int 27:453-460.
36. Reiter RJ, Tan D-X. 2003. Melatonin: A novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 58:10-19.
37. Reiter RJ, Tan D-X, Osuna C, Gitto E. 2000. Actions of melatonin in the reduction of oxidative stress: A review. J Biomed Sci 7:444-458.
38. Ritz B, Zhao Y, Krishnadasan A, Kennedy N, Morgenstern H. 2006. Estimated effects of hydrazine exposure on cancer incidence and mortality in aerospace workers. Epidemiology 17:154-161.
39. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Reiter RJ. 2004. Regulation of antioxidant enzymes: A significant role for melatonin. J Pineal Res 36:1-9.
40. Sainz RM, Mayo JC, Rodriguez C, Tan D-X, Lopez-Burillo S, Reiter RJ. 2003. Melatonin and cell death: Differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 60:1407-1426.
41. Sharma ML, Soni JL, Atta K. 1991. Pathomorphological changes in calf erythrocytes during phenylhydrazine-induced acute haemolytic anemia. Arch Exp Veterinarmed 5:45-78.
42. Shiu SY, Xi SC, Xu JN, Mei L, Pang SF, Yao KM, Wong JT. 2000. Inhibition of malignant trophoblastic cell proliferation in vitro and in vivo by melatonin. Life Sci 67:2059-2074.
43. Singh SS, Haldar C. 2005. Melatonin supplementation prevent exogenous testosterone induced suppression of immune parameters and splenocyte proliferation both in vivo and in vitro in Indian tropical bird, P. asiatica. Gen Comp Endocrinol 141:226-232.
44. Skwarlo-Sonta K. 2002. Melatonin in immunity: Comparative aspects. Neuro Endocrinol Lett 23(Suppl 1):61-66.
45. Snyder LM, Fortier NL, Trainor J, Jacobs J, Leb L, Lubin B, Chin D, Shohet S, Mohandas N. 1985. Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics and spectrin-hemoglobin cross-linking. J Clin Invest 76:1971-1977.
46. Sorrell JM, Weiss L. 1982. Development of the embryonic chick phagocytic system: Intraembryonic erythrophagocytosis induced by phenylhydrazine. J Morphol 171:183-194.
47. Tan D-X, Chen L-D, Poeggeler B, Manchester LC, Reiter RJ. 1993. Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocrine J 1:57-60. Tan D-X, Hardeland R, Manchester LC, Poeggeler B, Lopez-Burillo S, Mayo JC, Sainz RM, Reiter RJ. 2003. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with their interactions with the ABTS cation radical. J Pineal Res 34:249-259.
48. Toth B. 2000. A review of the natural occurrence, synthetic production and use of carcinogenic hydrazines and related chemicals. In Vivo 14:299-319.
49. Treeck O, Haldar C, Ortmann O. 2006. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines. Oncology Rep 15:231-235.
50. Vilsen B, Nielsen H. Reaction of phenylhydrazine with erythro-cytes. 1984. Cross-linking of spectrin by disulfide exchange with oxidized hemoglobin. Biochem Pharmacol 33:2739-2748.
51. Xie LD, Liu DH, Sun DG, Yao WJ, Gu L, Yan ZY, Wen ZY. 2002. Study on the membrane shear elastic modul and viscosity of reticulocytes. Progr Biochem Biophys 29:776-780.
52. Xie LD, Gu L, Yan ZY, Yao WJ, Sun DG, Wen ZY. 2003. The microrheological changes in the course of erythrocyte senescence after phenylhydrazine injection. Clin Hemorheol Microcirc 28:5-11.